Contributions of biotechnology to the control and prevention of brucellosis in Africa

African Journal of Biotechnology

Volumn 3, Issue 12, 2004, Pages 631-636

  Smits, Henk L ^a   Cutler, Sally J ^b  

^a ROYAL TROPICAL INSTITUTE   (Netherlands)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Biotechnology; Brucellosis; Diagnostics; Livestock; Public health; Vaccine; Zoonosis

Indexed keywords

BRUCELLA VACCINE;

AFRICA; BIOTECHNOLOGY; BRUCELLOSIS; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DISEASE CONTROL; NONHUMAN; PROPHYLAXIS; REDUCTION; REVIEW; VACCINATION; ZOONOSIS;

EID: 15744400134     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D (2003). Laboratory-based diagnosis of brucellosis - a review of the literature. Part II: serological tests for brucellosis. Clin. Lab. 49: 577-589.
2. Al Dahouk S, Tomaso H, Nockler K, Neubauer H (2004). The detection of Brucella spp. using PCR-ELISA and real-time PCR assays. Clin. Lab. 50: 387-394.
3. Al-Shamahy HA, Whitty CJ, Wright SG (2000). Risk factors for human brucellosis in Yemen: a case control study. Epidemiol. Infect. 125: 309-13.
4. Baba MM, Sarkindared SE, Brisibe F (2001). Serological evidence of brucellosis among predisposed patients with pyrexia of unknown origin in the north eastern Nigeria. Cent. Eur. J. Public Health. 9: 158-161.
5. Bikas C, Jelastopulu E, Leotsinidis M, Kondakis X (2003). Epidemiology of human brucellosis in a rural area of north-western Peloponnese in Greece. Eur. J. Epidemiol. 18: 267-274.
6. Chantal J, Bessiere MH, Le Guenno B, Magnaval JF, Dorchies P (1996). Serologic screening of certain zoonoses in the abattoir personnel in Djibouti. Bull. Soc. Pathol. Exot. 89: 353-357.
7. Corbell MJ (1997). Brucellosis: an overview. Emerg. Infect. Dis. 3:213-221.
8. Coulibaly ND, Yameogo KR (2000). Prevalence and control of zoonotic diseases: collaboration between public health workers and veterinarians in Burkina Faso. Acta Trop. 76: 53-57.
9. Dajer A, Luna-Martinez E, Zapata D, Villegas S, Gutierrez E, Pena G, Gurria F, Nielsen K, Gall D (1999). Evaluation of a fluorescencepolarization assay for the diagnosis of bovine brucellosis in Mexico. Prev. Vet. Med. 40: 67-73.
10. DelVecchio VG, Kapatral V, Redkar RJ, Patra G, Mujer C, Los T, Ivanova N, Anderson I, Bhattacharyya A, Lykidis A, Reznik G, Jablonski L, Larsen N, D'Souza M, Bernal A, Mazur M, Goltsman E, Selkov E, Elzer PH, Hagius S, O'Callaghan D, Letesson JJ, Haselkorn R, Kyrpides N, Overbeek R (2002). The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc. Natl. Acad. Sci. USA. 99: 443-448.
11. DelVecchio VG, Wagner MA, Eschenbrenner M, Horn TA, Kraycer JA, Estock F, Elzer P, Mujer CV (2002) Brucella proteomes - a review. Vet. Microbiol. 90: 593-603.
12. DelVecchio VG, Kapatral V, Elzer P, Patra G, Mujer CV (2002). The genome of Brucella melitensis. Vet. Microbiol. 90: 587-592.
13. Domingo AM (2000). Current status of some zoonoses in Togo. Acta Trop. 76: 65-9.
14. Emanuel PA, Bell R, Dang JL, McClanahan R, David JC, Burgess RJ, Thompson J, Collins L, Hadfield T (2003). Detection of Francisella tularensis within infected mouse tissues by using a hand-held PCR thermocycler. J. Clin. Microbiol. 41: 689-693.
15. El-Ansary EH, Mohammed BA, Hamad AR, Karom AG (2001). Brucellosis among animals and human contacts in eastern Sudan. Saudi Med. J. 22: 577-579.
16. Elberg SS, Faunce K (1957). Immunization against Brucella infection. VI. Immunity conferred on goats by a nondependent mutant from a streptomycin- dependent mutant strain of Brucella melitensis. J. Bacteriol. 73: 211-217.
17. Emslie FR, Nel JR (2002) An overview of the eradication of Brucella melitensis from KwaZulu-Natal. Onderstepoort J. Vet. Res. 69: 123-127.
18. Godfroid J (2002). Brucellosis in wildlife. Rev. Sci .Tech. 21: 277-286.
19. Gotuzzo E, Seas C, Guerra JG, Carrillo C, Bocanegra TS, Calvo A, Castaneda O, Alarcon GS (1987). Brucellar arthritis: a study of 39 Peruvian families. Ann. Rheum. Dis. 46: 506-9.
20. Irmak H, Buzgan T, Evirgen O, Akdeniz H, Demiroz AP, Abdoel TH, Smits HL (2004). Use of the Brucella IgM and IgG flow assays in the serodiagnosis of human brucellosis in an area endemic for brucellosis. Am. J. Trop. Med. Hyg.70: 688-694.
21. Kabagambe EK, Elzer PH, Geaghan JP, Opuda-Asibo J, Scholl DT, Miller JE (2001). Risk factors for Brucella seropositivity in goat herds in eastern and western Uganda. Prev. Vet. Med. 52: 91-108.
22. Kadohira M, McDermott JJ, Shoukri MM, Kyule MN (1997). Variations in the prevalence of antibody to brucella infection in cattle by farm, area and district in Kenya. Epidemiol. Infect. 118: 35-41.
23. Kubuafor DK, Awumbila B, Akanmori BD (2000). Seroprevalence of brucellosis in cattle and humans in the Akwapim-South district of Ghana: public health implications. Acta Trop. 76: 45-48.
24. Lithg-Pereira PL, Rojo-Vazquez FA, Mainar-Jaime RC (2004). Case-control study of risk factors for high within-flock small-ruminant brucellosis prevalence in a brucellosis low-prevalence area. Epidemiol. Infect.132:201-210.
25. Maichomo MW, McDermott JJ, Arimi SM, Gathura PB (1998). Assessment of the Rose-Bengal plate test for the diagnosis of human brucellosis in health facilities in Narok district, Kenya. East Afr. Med. J. 75: 219-222.
26. McDermott JJ, Arimi SM (2002). Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet. Microbiol. 90: 111-134.
27. Mikolon AB, Gardner IA, Hernandez De Anda J, Hietala SK (1998). Risk factors for brucellosis seropositivity of goat herds in the Mexicali Valley of Baja California, Mexico. Prev. Vet. Med. 37: 185-195.
28. Minas A, Minas M, Stournara A, Tselepidis S (2004).The "effects" of Rev-1 vaccination of sheep and goats on human brucellosis in Greece. Prev. Vet. Med. 64: 41-47.
29. Mohan K, Makaya PV, Muvavarirwa P, Matope G, Mahembe E, Pawandiwa A (1996). Brucellosis surveillance and control in Zimbabwe: bacteriological and serological investigation in dairy herds. Onderstepoort J. Vet. Res. 63: 47-51.
30. Muriuki SM, McDermott JJ, Arimi SM, Mugambi JT, Wamola IA (1997). Criteria for better detection of brucellosis in the Narok District of Kenya. East Afr. Med. J. 74: 317-320.
31. Mutanda LN (1998). Selected laboratory tests in febrile patients in Kampala, Uganda. East Afr. Med. J. 75: 68-72.
32. Nakoune E, Debaere O, Koumanda-Kotogne F, Selekon B, Samory F, Talarmin A (2004). Serological surveillance of brucellosis and Q fever in cattle in the Central African Republic. Acta Trop. 92: 147-151.
33. Nicoletti P (1990) Vaccination against Brucella. Adv. Biotechnol. Processes. 3: 147-168.
34. Nielsen K, Gall D, Smith P, Kelly W, Yeo J, Kenny K, Heneghan T, McNamara S, Maher P, O'Connor J, Walsh B, Carroll J, Rojas X, Rojas F, Perez B, Wulff O, Buffoni L, Salustio E, Gregoret R, Samartino L, Dajer A, Luna-Martinez E (2001). Fluorescence polarization assay for the diagnosis of bovine brucellosis: adaptation to field use. Vet. Microbiol. 80: 163-170.
35. Ocholi RA, Ezeokoli CD, Akerejola OO, Saror DI (1996) Use of the enzyme-linked immunosorbent assay for screening cattle for Brucella antibodies in Nigeria. Vet. Q.18: 22-24.
36. Omer MK, Skjerve E, Woldehiwet Z, Holstad G (2000) Risk factors for Brucella spp. infection In dairy cattle farms in Asmara, State of Eritrea. Prev Vet Med. 46: 257-265.
37. Omer MK, Skjerve E, Holstad G, Woldehiwet Z, Macmillan AP (2000) Prevalence of antibodies to Brucella spp. in cattle, sheep, goats, horses and camels in the State of Eritrea; influence of husbandry systems. Epidemiol Infect. 125: 447-453.
38. Omer MK, Skjerve E, MacMillan AP, Woldehiwet Z (2001) Comparison of three serological tests in the diagnosis of Brucella infection in unvaccinated cattle in Eritrea. Prev. Vet Med. 48: 215-222.
39. Omer MK, Assefaw T, Skjerve E, Tekleghiorghis T, Woldehiwet Z (2002) Prevalence of antibodies to Brucella spp. and risk factors related to high-risk occupational groups in Eritrea. Epidemiol Infect. 129: 85-91.
40. Orduna A, Almaraz A, Prado A, Gutierrez MP, Garcia-Pascual A, Duenas A, Cuervo M, Abad R, Hernandez B, Lorenzo B, Bratos MA, Torres AR (2000) Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J Clin Microbiol. 38: 4000-4005.
41. Paulsen IT, Seshadri R, Nelson KE, Eisen JA, Heidelberg JF, Read TD, Dodson RJ, Umayam L, Brinkac LM, Beanan MJ, Daugherty SC, Deboy RT, Durkin AS, Kolonay JF, Madupu R, Nelson WC, Ayodeji B, Kraul M, Shetty J, Malek J, Van Aken SE, Riedmuller S, Tettelin H, Gill SR, White O, Salzberg SL, Hoover DL, Lindler LE, Halling SM, Boyle SM, Fraser CM (2002). The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc. Natl. Acad. Sci. USA. 99: 13148-13153.
42. Pavlou AK, Turner AP (2000). Sniffing out the truth: clinical diagnosis using the electronic nose. Clin. Chem. Lab. Med. 38: 99-112.
43. Perry BD, Randolph TF, McDermott JJ, Sones KR, Thornton PK (2002). Investing in animal health research to alleviate poverty. Intl. Livestock Res. Inst. Nairobi, Kenya.
44. Reviriego FJ, Moreno MA, Dominguez L (2000). Risk factors for brucellosis seroprevalence of sheep and goat flocks in Spain. Prev. Vet. Med. 44: 167-173.
45. Refai M (2002). Incidence and control of brucellosis in the Near East region. Vet. Microbiol. 20: 81-110.
46. Roth F, Zinsstag J, Orkhon D, Chimed-Ochir G, Hutton G, Cosivi O, Carrin G, Otte J (2003). Human health benefits from livestock vaccination for brucellosis: case study. Bull. World Health Organ. 81: 867-876.
47. Tonukari NJ (2004). Fostering biotechnology entrepreneurship in developing countries. Afr. J. Biotechnol. 3: 299-301.
48. Turkson PK, Boadu DQ (1992). Epidemiology of bovine brucellosis in the coastal savanna zone of Ghana. Acta Trop. 52: 39-43.
49. Turner AP, Magan N (2004).Electronic noses and disease diagnostics. Nat. Rev. Microbiol. 2: 161-166.
50. Samartino LE (2002). Brucellosis in Argentina. Vet. Microbiol. 90:71-80.
51. Schelling E, Diguimbaye C, Daoud S, Nicolet J, Boerlin P, Tanner M, Zinsstag J (2003). Brucellosis and Q-fever seroprevalences of nomadic pastoralists and their livestock in Chad. Prev. Vet. Med. 61: 279-293.
52. Schurig GG, Sriranganathan N, Corbel MJ (2002). Brucellosis vaccines: past, present and future. Vet. Microbiol. 90: 479-496.
53. Smits HL, Abdoel TH, Solera J, Clavijo E, Diaz R (2003). Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis. Clin. Diagn. Lab. Immunol. 10: 1141-1146.
54. Tounkara K, Maiga S, Traore A, Seck BM, Akakpo AJ (1994). Epidemiology of bovine brucellosis in Mali: serologic investigation and initial isolation of strains of Brucella abortus. Rev. Sci. Tech. 13: 777-786.
55. Weinhaupl I, Schopf KC, Khaschabi D, Kapaga AM, Msami HM (2000). Investigations on the prevalence of bovine tuberculosis and brucellosis in dairy cattle in Dares Salaam region and in zebu cattle in Lugoba area, Tanzania. Trop. Anim. Health Prod. 32: 147-154.
56. Young EJ (1995). An overview of human brucellosis. Clin. Infect. Dis. 21: 283-289.